Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMitchells & Butlers Regulatory News (MAB)

Share Price Information for Mitchells & Butlers (MAB)

Share Price is delayed by 15 minutes
Get Live Data
240.50    5.00 (2.12%)
Bid:
239.00
Ask:
240.00
Spread: 1.00 (0.418%)
Market Cap: £1.43b
MAB Live PriceLast checked at - London Stock Exchange

Intraday Mitchells & Butlers Share Chart

Board Changes

28 May 2021 10:15

RNS Number : 1920A
Mitchells & Butlers PLC
28 May 2021
 

28 May 2021

Mitchells & Butlers plc

LEI no. 213800JHYNDNB1NS2W10

 

Board Changes

 

 

Mitchells & Butlers plc announces the following changes to its Board.

 

Ron Robson, who joined the Board in 2010, and is a nominated representative of the Group's largest shareholder, the Odyzean Group, Imelda Walsh, Chair of the Remuneration Committee, and Colin Rutherford, Chair of the Audit Committee, who both joined the Board in 2013, will all retire from the Board at the end of July 2021.

 

Following these changes , the Board of M&B will be comprised of the non-executive chairman, Bob Ivell, two executive directors (Phil Urban, CEO and Tim Jones, CFO), three independent non-executive directors (Susan Murray, who will remain as senior independent director, Jane Moriarty, who will assume the role of chair of the Audit Committee, and Dave Coplin, who will continue in his role as non-executive director nominated for representation of the "workforce voice") and three non-executive directors representing the interests of the Odyzean Group (Eddie Irwin, Josh Levy and Keith Browne).

 

An announcement in relation to the chairmanship of the Remuneration Committee is expected to be made in the next few months.

 

The office of Deputy Chairman currently held by Mr Robson will not be continued.

 

Commenting on these changes, chairman Bob Ivell said:

 

Ron, Imelda and Colin have provided excellent service to M&B throughout their time on the Board, helping to achieve a significant period of stability for the Company whilst assisting our governance and oversight arrangements.

 

We are extremely grateful to all three of these highly regarded non-executive directors for the support, guidance and enthusiasm which they have brought to the Board and everyone at M&B wishes them every success for the future.

 

In its prospectus issued on 22 February 2021, the Company confirmed that the Odyzean Group, which comprises shareholders with a majority of the shares in the Company, would review the composition of the Board to streamline its decision making and reduce the number of non-executive directors. By making these changes now, the smaller, more agile Board is in line with the Company's stated intentions at the time of the equity raise and it can now focus on supporting and challenging management over the coming months, as the business first recovers and then moves forward again.

 

We hope to make a further announcement in the near future in relation to the position of chair of the Remuneration Committee which should conclude this process.

 

For further information, please contact:

 

Greg McMahon

Company Secretary & General Counsel

0121 498 6514

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADKFBPFBKKAPB
Date   Source Headline
30th Nov 20182:00 pmRNSDirector/PDMR Shareholding
30th Nov 201811:30 amRNSTotal Voting Rights
29th Nov 20182:00 pmRNSDirector/PDMR Shareholding
29th Nov 20182:00 pmRNSDirector/PDMR Shareholding
22nd Nov 20187:00 amRNSFull Year Results
19th Nov 20182:00 pmRNSDirector/PDMR Shareholding
9th Nov 201812:00 pmRNSNotice of Final Results
8th Nov 201810:00 amRNSHolding(s) in Company
31st Oct 20182:30 pmRNSTotal Voting Rights
22nd Oct 201811:45 amRNSDirector/PDMR Shareholding
8th Oct 20182:30 pmRNSChange to Director's Details - Imelda Walsh
5th Oct 20183:17 pmRNSHolding(s) in Company
1st Oct 201810:30 amRNSTotal Voting Rights
1st Oct 201810:30 amRNSBlock listing Interim Review
27th Sep 20187:00 amRNSPre-Close Trading Update
25th Sep 201810:00 amRNSHolding(s) in Company
24th Sep 20182:30 pmRNSDirector/PDMR Shareholding
20th Sep 20182:30 pmRNSNotice of Pre-Close Trading Statement
14th Sep 201811:00 amRNSDirectorate Change
31st Aug 201812:00 pmRNSTotal Voting Rights
28th Aug 201811:15 amRNSDirector/PDMR Shareholding
3rd Aug 20184:15 pmRNSHolding(s) in Company
2nd Aug 20181:00 pmRNSDirector/PDMR Shareholding
2nd Aug 20187:00 amRNSThird Quarter Trading Update
31st Jul 201811:30 amRNSTotal Voting Rights
30th Jul 201812:00 pmRNSDirector/PDMR Shareholding
25th Jul 201810:00 amRNSHolding(s) in Company
24th Jul 20182:30 pmRNSNotice of Third Quarter Trading Update
13th Jul 20182:30 pmRNSHolding(s) in Company
12th Jul 201810:30 amRNSAdditional Listing
11th Jul 201810:15 amRNSHolding(s) in Company
4th Jul 20182:00 pmRNSDirector/PDMR Shareholding
2nd Jul 20182:00 pmRNSDirector/PDMR Shareholding
29th Jun 20182:30 pmRNSTotal Voting Rights
21st Jun 20182:45 pmRNSDirector/PDMR Shareholding
21st Jun 20182:45 pmRNSDirector/PDMR Shareholding
4th Jun 20183:30 pmRNSDirector/PDMR Shareholding
1st Jun 201810:30 amRNSHolding(s) in Company
31st May 20184:02 pmRNSTotal Voting Rights
31st May 201810:30 amRNSHolding(s) in Company
16th May 20187:00 amRNSHalf Year Results
8th May 20183:30 pmRNSDirector/PDMR Shareholding
30th Apr 201811:00 amRNSTotal Voting Rights
18th Apr 20183:00 pmRNSNotice of Half Year Results
17th Apr 20184:51 pmRNSHolding(s) in Company
13th Apr 20183:46 pmRNSHolding(s) in Company
9th Apr 20183:00 pmRNSDirector/PDMR Shareholding
3rd Apr 20182:00 pmRNSBlock listing Interim Review
29th Mar 201811:45 amRNSTotal Voting Rights
15th Mar 201810:00 amRNSChange to Director's Details - Dave Coplin

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.